2025-01-17 00:49:28
Adlai Nortye Announces First Patient Dosed in Phase Ia Clinical Trial of AN2025 and AN0025 in Combination with atezolizumab for Advanced Solid Tumors
Health/ 2023-07-22
Adlai Nortye Announces First Patient Dos...

NORTH BRUNSWICK,New Jerseyand HANGZHOU,China,Sept. 8,2021-- Adlai Nortye,a global biopharmaceutical company focused on developing innovative...

Yiling Pharmaceutical's Yishen Yangxin Anshen Tablets Granted Drug Certificate
Health/ 2023-07-22
Yiling Pharmaceutical's Yishen Yang...

SHIJIAZHUANG,China,Sept. 8,2021-- Yiling Pharmaceutical recently announced that its newly-developed drug Yishen Yangxin Anshen Tablet had be...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release